Medication Safety
Featured Article
The FDA has issued a Class II recall for a prescription treatment used for patients with severe acne.
A prescription ophthalmic solution used to reduce pressure inside the eye from glaucoma is being recalled.
Two more firms have announced voluntary recalls of ranitidine products due to contamination with the probable human carcinogen NDMA.